284 related articles for article (PubMed ID: 36380976)
1. Therapeutic Strategies in the Fight against COVID-19: From Bench to Bedside.
Abadi B; Aarabi Jeshvaghani AH; Fathalipour H; Dehghan L; Rahimi Sirjani K; Forootanfar H
Iran J Med Sci; 2022 Nov; 47(6):517-532. PubMed ID: 36380976
[TBL] [Abstract][Full Text] [Related]
2. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
Front Immunol; 2021; 12():658519. PubMed ID: 34276652
[TBL] [Abstract][Full Text] [Related]
3. A perspective on SARS-CoV-2 virus-like particles vaccines.
Gao X; Xia Y; Liu X; Xu Y; Lu P; Dong Z; Liu J; Liang G
Int Immunopharmacol; 2023 Feb; 115():109650. PubMed ID: 36649673
[TBL] [Abstract][Full Text] [Related]
4. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
5. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
6. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
7. The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses.
Muhar BK; Nehira J; Malhotra A; Kotchoni SO
J Pharm Pract; 2023 Aug; 36(4):953-966. PubMed ID: 35723017
[TBL] [Abstract][Full Text] [Related]
8. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
9. Super-rapid race for saving lives by developing COVID-19 vaccines.
Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A
J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582
[TBL] [Abstract][Full Text] [Related]
10. Development of vaccines for SARS-CoV-2.
Ng WH; Liu X; Mahalingam S
F1000Res; 2020; 9():. PubMed ID: 32850116
[TBL] [Abstract][Full Text] [Related]
11. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
12. COVID-19, the firestone in 21st century: a review on coronavirus disease and its clinical perspectives.
Karthika C; Swathy Krishna R; Rahman MH; Akter R; Kaushik D
Environ Sci Pollut Res Int; 2021 Dec; 28(46):64951-64966. PubMed ID: 34599450
[TBL] [Abstract][Full Text] [Related]
13. The 2020 race towards SARS-CoV-2 specific vaccines.
Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
[TBL] [Abstract][Full Text] [Related]
14. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
15. Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease.
Bhagat S; Yadav N; Shah J; Dave H; Swaraj S; Tripathi S; Singh S
Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1275-1298. PubMed ID: 33043740
[TBL] [Abstract][Full Text] [Related]
16. An overview on inactivated and live-attenuated SARS-CoV-2 vaccines.
Khoshnood S; Arshadi M; Akrami S; Koupaei M; Ghahramanpour H; Shariati A; Sadeghifard N; Heidary M
J Clin Lab Anal; 2022 May; 36(5):e24418. PubMed ID: 35421266
[TBL] [Abstract][Full Text] [Related]
17. Are We Paving the Way to Dig Out of the "Pandemic Hole"? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization.
Tardiolo G; Brianti P; Sapienza D; dell'Utri P; Dio VD; Rao G; Calabrò RS
Med Sci (Basel); 2021 Jul; 9(3):. PubMed ID: 34449681
[TBL] [Abstract][Full Text] [Related]
18. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: Coronavirus Vaccine Development Updates.
Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
Front Immunol; 2020; 11():602256. PubMed ID: 33424848
[TBL] [Abstract][Full Text] [Related]
20. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference.
Mukherjee S; Ray SK
Infect Disord Drug Targets; 2022; 22(4):e080222200919. PubMed ID: 35135456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
